‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
PSA recommendations to improve medicine use in disability care
A critical lack of information about medicine use by people with disability prevents pharmacists from promoting the quality use of medicines within a vulnerable group.
Can pharmacists help prevent doping in sport?
The recent release of the updated 2019 List of Prohibited Substances and Methods from the World-Anti-Doping Agency (WADA) raises the question about the relationship...
Pharmacists funded under new medicine safety trial
A new intervention will target medicine safety in primary care, with the aim of reducing medicine-related hospitalisations by identifying at-risk patients.
New beginnings for PSA’s Pharmacist of the Year
Congratulations PSA Pharmacist of the Year Faye McMillan MPS for her appointment as Professor of Indigenous Health at UTS.
Improving gout management one step at a time
Gout is a chronic arthritis associated with significant pain, joint damage and reduced quality of life. However, it can be effectively treated and its complications prevented with adherence to lifelong ULT using a treat-to-target approach.
Unlocking the power of effective communication in medicines reviews
Good communication skills, supported by evidence-based information, are essential for quality outcomes from collaborative medication reviews.
